抗体
试剂盒
多肽
探针
蛋白
组织芯片
产品中心
Product Center
Research Grade Olinvacimab
All
TD-HW338026_1.jpg
TD-HW338026_2.jpg
- Catalog： TD-HW338026
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： SSS-23,TTAC-0001,tanibirumab,CAS:2095504-49-5
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Olinvacimab
| Catalog No. | TD-HW338026 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Humanized |
| Isotype | IgG1-kappa-lambda |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | FLK-1, Kinase insert domain receptor, VEGFR2, Fetal liver kinase 1, CD309, Vascular endothelial growth factor receptor 2, Protein-tyrosine kinase receptor flk-1, FLK1, VEGFR-2, KDR |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | P35968 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | SSS-23,TTAC-0001,tanibirumab,CAS:2095504-49-5 |
| Background | Olinvacimab (TTAC-0001) is a fully human anti-VEGFR2 monoclonal antibody. Olinvacimab inhibits VEGF binds to VEGFR2/KDR/Flk-1 with a Kd value of 0.23 nM. Olinvacimab has antiangiogenic activity. Olinvacimab can be used for the research of recurrent glioblastoma and breast cancer. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
SEC-HPLC detection for Research Grade Olinvacimab. |
|
|
Detects Human CD309/KDR/VEGFR-2 in direct ELISAs. |